BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mucha O, Podkalicka P, Kaziród K, Samborowska E, Dulak J, Łoboda A. Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy. Skelet Muscle 2021;11:21. [PMID: 34479633 DOI: 10.1186/s13395-021-00276-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Nesari V, Balakrishnan S, Nongthomba U. Is the fundamental pathology in Duchenne's muscular dystrophy caused by a failure of glycogenolysis–glycolysis in costameres? J Genet 2023;102:13. [DOI: 10.1007/s12041-022-01410-w] [Reference Citation Analysis]
2 Loboda A, Dulak J. NRF2 and its targets in skeletal muscle repair and regeneration. Antioxid Redox Signal 2023. [PMID: 36597355 DOI: 10.1089/ars.2022.0208] [Reference Citation Analysis]
3 White Z, Sun Z, Sauge E, Cox D, Donen G, Pechkovsky D, Straub V, Francis GA, Bernatchez P. Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice. Skelet Muscle 2022;12:25. [PMID: 36447272 DOI: 10.1186/s13395-022-00308-6] [Reference Citation Analysis]
4 Lin C, Han G, Jia L, Zhao Y, Song J, Ran N, Yokota T, Seow Y, Yin H. Cardio‐respiratory and phenotypic rescue of dystrophin/utrophin‐deficient mice by combination therapy. EMBO Reports 2022;23. [DOI: 10.15252/embr.202153955] [Reference Citation Analysis]
5 Campos LM, Guapyassu L, Gomes C, Midlej V, Benchimol M, Mermelstein C, Costa ML. Simvastatin and Muscle: Zebrafish and Chicken Show that the Benefits are not Worth the Damage. Front Cell Dev Biol 2022;10:778901. [DOI: 10.3389/fcell.2022.778901] [Reference Citation Analysis]
6 Podkalicka P, Mucha O, Kaziród K, Szade K, Stępniewski J, Ivanishchuk L, Hirao H, Pośpiech E, Józkowicz A, Kupiec-Weglinski JW, Dulak J, Łoboda A. miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy. Sci Rep 2022;12:3945. [PMID: 35273230 DOI: 10.1038/s41598-022-07868-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bourg N, Vu Hong A, Lostal W, Jaber A, Guerchet N, Tanniou G, Bordier F, Bertil-Froidevaux E, Georger C, Daniele N, Richard I, Israeli D. Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy. Int J Mol Sci 2022;23:2016. [PMID: 35216132 DOI: 10.3390/ijms23042016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kaziród K, Myszka M, Dulak J, Łoboda A. Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases. Cell Mol Life Sci 2022;79:608. [PMID: 36441348 DOI: 10.1007/s00018-022-04636-0] [Reference Citation Analysis]